Experiment 813954

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismMaytenus buchananii (CELASTRACEAE)
CitationO'CONNELL,MJ: SHANI,A: RUBIN,J: MOERTEL,CG:. (1978). PHASE II. TRIAL OF MAYTANSINE IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMA.. 62()
Amount utilized
Compound isolated
DiseasePHASE II TRIAL OF 31 PATIENTS(43-84 YRS),ALL HAVING COLORECTAL ADENOCARCINOMA NO PATIENTS IN THE STUDY EXPERIENCED AN OBJECTIVE TUMOR REGRESSION DOSING WAS FOR 3 CONSECUTIVE DAYS AND REPEATING AT 3 WEEK INTERVALS FOR FIRST 2 CYCLES,THEN Q 4 WKS
Dose amount0.60 MG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES